[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337210-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337210-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","thyroid-carcinoma-glycoproteins-express-altered-n-glycans-with-3-o-sulfated-galactose-residues-research-findings-and-biomolecular-analysis","Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues - Research findings and biomolecular analysis","","Aberrant protein glycosylation is closely linked to cancer progression, yet the N-glycosylation of papillary thyroid cancer (PTC) glycoproteins remains insufficiently characterized. This study compares freshly prepared PTC specimens with paired normal tissue from thyroidectomies using mass spectrometry for Asn-linked (N)-glycans and Western blotting with lectins and the O6 monoclonal antibody specific for 3-O-sulfated galactose residues. PTC samples show increased N-glycan branching and GlcNAc bisection, and 3-O-sulfated galactose is detected across multiple glycoproteins in both PTC and control groups. Results clarify altered N-glycan features in thyroid cancer and support future biomarker and therapeutic target research.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/thyroid-carcinoma-glycoproteins-express-altered-n-glycans-with-3-o-sulfated-galactose-residues-research-findings-and-biomolecular-analysis/337210/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/thyroid-carcinoma-glycoproteins-express-altered-n-glycans-with-3-o-sulfated-galactose-residues-research-findings-and-biomolecular-analysis/337210.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes protein glycosylation relevant to cancer in this study?","Question",{"text":63,"@type":64},"The study treats aberrant protein glycosylation as a hallmark of cancer and notes that glycan changes correlate with cancer development and progression. It highlights altered N- and O-glycosylation patterns as key tumor-associated features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PTC and normal tissues analyzed for glycan changes?",{"text":68,"@type":64},"Freshly prepared PTC specimens and paired normal tissues were examined using glycomic approaches focused on Asn-linked (N)-glycans. Mass spectrometry was used, alongside Western blotting with specific lectins and the O6 monoclonal antibody for 3-O-sulfated galactose residues.",{"name":70,"@type":61,"acceptedAnswer":71},"What glycan alterations were observed in PTC compared with paired normal specimens?",{"text":72,"@type":64},"PTC specimens displayed higher N-glycan branching and GlcNAc bisection compared with paired normal tissue, consistent with RNAseq data. The study also found 3-O-sulfated galactose present in N-glycans of multiple glycoproteins recognized by the O6 antibody and confirmed by mass spectrometry.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337210,1790443540,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \nThyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues  \nJordan M. Broekhuis†, Dongli Lu‡, Rajindra P. Aryal , Yasuyuki Matsumoto §, Lauren E. Pepi , Natalia Chaves , Jorge L. Gomez-Mayorga , Benjamin C. James and Richard D. Cummings *  \nCitation: Broekhuis, J.M.; Lu, D.; Aryal, R.P.; Matsumoto, Y.; Pepi, L.E.; Chaves, N.; Gomez-Mayorga, J.L.; James, B.C.; Cummings, R.D. Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues. Biomolecules 2024, 14, 1482. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biom14121482  \nAcademic Editor: Lu-Gang Yu  \nReceived: 17 October 2024  \nRevised: 8 November 2024  \nAccepted: 11 November 2024  \nPublished: 21 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA;  \n[jbroekhuis@mgb.org](jbroekhuis@mgb.org) (J.M.B.); [dongli.lu@cshs.org](dongli.lu@cshs.org) (D.L.); [rparyal@bidmc.harvard.edu](rparyal@bidmc.harvard.edu) (R.P.A.);  \n[yasuyuki.matsumoto@fda.hhs.gov](yasuyuki.matsumoto@fda.hhs.gov) (Y.M.); [lpepi@bidmc.harvard.edu](lpepi@bidmc.harvard.edu) (L.E.P.);  \n[nchaves1@bidmc.harvard.edu](nchaves1@bidmc.harvard.edu) (N.C.); [jgomez7@bidmc.harvard.edu](jgomez7@bidmc.harvard.edu) (J.L.G.-M.);  \n[bjames1@bidmc.harvard.edu](bjames1@bidmc.harvard.edu) (B.C.J.)  \n* Correspondence: [rcummin1@bidmc.harvard.edu](rcummin1@bidmc.harvard.edu)  \n† Current address: Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.  \n‡ Current address: Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.  \n§ Current address: Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.  \nAbstract: Aberrant protein glycosylation is a hallmark alteration of cancer and is highly associated with cancer progression. Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, but the N-glycosylation of its glycoproteins has not been well characterized. In this work, we analyzed multiple freshly prepared PTC specimens along with paired normal tissue obtained from thyroidectomies. Glycomic analyses focused on Asn-linked (N)-glycans and employed mass spectrometry (MS), along with Western blot approaches of total solubilized materials that were examined for binding by specific lectins and a monoclonal antibody (mAb) O6, specific for 3-O-sulfated galactose residues. We observed major differences in PTC versus paired normal specimens, as PTC specimens exhibited higher levels of N-glycan branching and bisection with N-acetylglucosamine residues, consistent with RNAseq data. We also found that 3-O-sulfated galactose was present in N-glycans of multiple glycoproteins from both PTC and control specimens, as recognized by the O6 mAb and as confirmed by MS analyses. These results provide new insights into the N-glycans present in glycoproteins of thyroid cancer and context for further studies of these altered glycans as biomarkers and targets for therapeutics.  \nKeywords: GlcNAc bisection; glycosylation; lectin histochemistry; mass spectrometry; papillary thyroid cancer; RNAseq; sialylation; sulfation; sulfoglycomics; thyroid carcinoma; western blotting  \n1. Introduction  \nAberrant glycosylation in glycoproteins is a hallmark of cancer, caused in part by changes in the expression of glycogenes and disruption of regular cellular events during cancer progression [1–5] . Fundamentally, glycosylation is the most abundant and varied post-tra","cbCaiqF7rHwUWSgT","https://ap.wps.com/l/cbCaiqF7rHwUWSgT","pdf",2530998,"English","# Introduction\n## Glycosylation as a cancer hallmark\n## Thyroid cancer epidemiology and PTC prevalence\n## Existing research on thyroid glycoprotein glycosylation","[{\"question\":\"What makes protein glycosylation relevant to cancer in this study?\",\"answer\":\"The study treats aberrant protein glycosylation as a hallmark of cancer and notes that glycan changes correlate with cancer development and progression. It highlights altered N- and O-glycosylation patterns as key tumor-associated features.\"},{\"question\":\"How were PTC and normal tissues analyzed for glycan changes?\",\"answer\":\"Freshly prepared PTC specimens and paired normal tissues were examined using glycomic approaches focused on Asn-linked (N)-glycans. Mass spectrometry was used, alongside Western blotting with specific lectins and the O6 monoclonal antibody for 3-O-sulfated galactose residues.\"},{\"question\":\"What glycan alterations were observed in PTC compared with paired normal specimens?\",\"answer\":\"PTC specimens displayed higher N-glycan branching and GlcNAc bisection compared with paired normal tissue, consistent with RNAseq data. The study also found 3-O-sulfated galactose present in N-glycans of multiple glycoproteins recognized by the O6 antibody and confirmed by mass spectrometry.\"}]","Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues - Research findings and biomolecular analysis | PDF",1790018172,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3319ea02932f14b7af201710e2e9d15.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0136a3962503769ec3816898c7d6280.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a9aa1ef3ff252ed44e1210b5cb6957e.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/147c86d15ddda442dbf1740d44865c35.webp",980,1385]